{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:40:14Z","timestamp":1787316014435,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52130301"],"award-info":[{"award-number":["52130301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071378"],"award-info":[{"award-number":["32071378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373137"],"award-info":[{"award-number":["52373137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.02.074","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:00:45Z","timestamp":1740510045000},"page":"113578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity"],"prefix":"10.1016","volume":"381","author":[{"given":"Jin","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.074_bb0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2022.03.032","article-title":"mRNA vaccines for COVID-19 and diverse diseases","volume":"345","author":"Hussain","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0020","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials of mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0030","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA9512","article-title":"Individualized neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma: 3-year update from the mRNA-4157-P201 (KEYNOTE-942) trial","volume":"42","author":"Weber","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Pan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"14","author":"Appay","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0055","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nri1250","article-title":"Making sense of mass destruction: quantitating MHC class I antigen presentation","volume":"3","author":"Yewdell","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1074-7613(03)00051-7","article-title":"Quantitating protein synthesis, degradation, and endogenous antigen processing","volume":"18","author":"Princiotta","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri2368","article-title":"The known unknowns of antigen processing and presentation","volume":"8","author":"Vyas","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0080","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/s41467-023-38751-8","article-title":"An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants","volume":"14","author":"Tai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax4100","article-title":"Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma","volume":"13","author":"Fidanza","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0090","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3390\/cells12141846","article-title":"Targeted protein degradation: principles and applications of the proteasome","volume":"12","author":"Kim","year":"2023","journal-title":"Cells-Basel"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrm3982","article-title":"The unravelling of the ubiquitin system","volume":"16","author":"Ciechanover","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","article-title":"Structural basis for the recognition of hydroxyproline in \u03b1IF-1\u03b1 by pVHL","volume":"417","author":"Hon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0110","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","article-title":"Generation of a live attenuated influenza a vaccine by proteolysis targeting","volume":"40","author":"Si","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1081","article-title":"PROTAC vaccine: a new way to live attenuated vaccines","volume":"12","author":"Li","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2022.03.033","article-title":"Delivery of mRNA for regulating functions of immune cells","volume":"345","author":"Shi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for Cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: a journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","article-title":"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins","volume":"19","author":"Yugawa","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0145","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.3084","article-title":"Retrospective cohort analysis of adjuvant NY-ESO-1 vaccines in stage III melanoma","volume":"34","author":"Lattanzi","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0150","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1038\/ncomms13312","article-title":"Potent and selective chemical probe of hypoxic signalling downstream of HIF-\u03b1 hydroxylation via VHL inhibition","volume":"7","author":"Frost","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-023-00385-8","article-title":"Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)","volume":"27","author":"Wang","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1097-4644(20000801)78:2<334::AID-JCB15>3.0.CO;2-F","article-title":"Human papillomavirus type 16 E6 and HPV-16 E6\/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation","volume":"78","author":"Liu","year":"2000","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","article-title":"The HPV E6\/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets","volume":"26","author":"Hoppe-Seyler","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nri2687","article-title":"Proteasomes in immune cells: more than peptide producers?","volume":"10","author":"Groettrup","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0175","first-page":"57","article-title":"Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number","volume":"26","author":"Sato","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0180","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 based immunotherapy of cancer: current perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0185","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.apsb.2020.08.004","article-title":"Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses","volume":"11","author":"Yang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0190","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41467-020-15073-7","article-title":"Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10","volume":"11","author":"Buel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0195","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1158\/2326-6066.CIR-22-0406","article-title":"CD69 imposes tumor-specific CD8+T-cell fate in tumor-draining lymph nodes","volume":"11","author":"Koyama-Nasu","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0200","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122628","article-title":"mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo","volume":"310","author":"Cao","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120844","article-title":"Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells","volume":"274","author":"Park","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jbiotec.2012.12.013","article-title":"Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity","volume":"164","author":"Chen","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0245","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni989","article-title":"Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain","volume":"4","author":"Liz\u00e9e","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.074_bb0255","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0260","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.074_bb0265","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:54:03Z","timestamp":1769219643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":53,"alternative-id":["S0168365925001877"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.074","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113578"}}